即将上市(暗盘交易时段:今日16:15-18:30)
| 公司名称▼
/
代号▼ | 行业 | 招股价 | 每手股数 | 入场费 | 招股截止日 | 暗盘日期▼ | 上市日期▲ |
| 盛禾生物控股 02898.HK | 生物技术 | 13.50 | 200 | 2,727 | 2024/05/21 |
2024/05/23 | 2024/05/24 |
年份 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 |
货币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
单位 | 千 | 千 | 千 | 千 | 千 |
经营活动之现金流量 | 256,691,000 | 173,760,000 | 203,712,000 | 214,441,000 | 165,818,000 |
投资回报及融资费用之现金流量 | -20,906,000 | -13,761,000 | -13,184,000 | -10,731,000 | -8,600,000 |
已收利息 | 10,349,000 | 8,506,000 | 4,923,000 | 5,610,000 | 6,230,000 |
已付利息 | -11,478,000 | -9,342,000 | -7,525,000 | -7,076,000 | -7,047,000 |
已收股息 | 2,011,000 | 2,192,000 | 3,324,000 | 2,153,000 | 1,670,000 |
已付股息 | -21,788,000 | -15,117,000 | -13,906,000 | -11,418,000 | -9,453,000 |
其他 | - | - | - | - | - |
退回/(已缴)税项 | -34,729,000 | -27,669,000 | -28,526,000 | -20,322,000 | -17,228,000 |
投资活动之现金流量 | -137,521,000 | -115,569,000 | -186,796,000 | -189,718,000 | -124,070,000 |
增添固定资产 | -21,365,000 | -23,205,000 | -31,006,000 | -39,417,000 | -27,122,000 |
出售固定资产 | 257,000 | 376,000 | 191,000 | - | 4,000 |
投资增加 | -71,754,000 | -66,598,000 | -160,258,000 | -121,274,245 | -76,695,000 |
投资减少 | 61,434,000 | 51,065,000 | 68,077,000 | 25,148,516 | 17,633,000 |
与关联人士之现金流量 | 655,000 | - | -10,124,000 | -1,271 | -5,030,000 |
其他 | -106,748,000 | -77,207,000 | -53,676,000 | -54,174,000 | -32,860,000 |
融资活动前之现金流量 | 63,535,000 | 16,761,000 | -24,794,000 | -6,330,000 | 15,920,000 |
融资活动之现金流量 | -49,307,000 | -35,494,000 | 43,051,000 | 32,141,000 | 18,172,000 |
新增贷款 | 63,450,000 | 30,236,000 | 56,451,000 | 31,413,000 | 73,450,000 |
偿还贷款 | -50,657,000 | -29,798,000 | -28,144,000 | -27,948,000 | -79,626,000 |
定息/债项工具融资 | - | - | 27,060,000 | 47,948,000 | 40,202,000 |
偿还定息/债项工具 | -10,141,000 | - | - | -10,460,000 | -13,465,000 |
股本融资 | 1,070,000 | 995,000 | 1,043,000 | 1,716,000 | 272,000 |
与关联人士之现金流量 | -4,642,000 | -4,738,000 | -8,362,000 | -8,663,000 | -209,000 |
其他 | -48,387,000 | -32,189,000 | -4,997,000 | -1,865,000 | -2,452,000 |
现金及等同现金之增加/(减少) | 14,228,000 | -18,733,000 | 18,257,000 | 25,811,000 | 34,092,000 |
年初之现金及现金等同项目 | 156,739,000 | 167,966,000 | 152,798,000 | 132,991,000 | 97,814,000 |
外汇兑换率变动之影响/(其他) | 1,353,000 | 7,506,000 | -3,089,000 | -6,004,000 | 1,085,000 |
年终之现金及现金等同项目 | 172,320,000 | 156,739,000 | 167,966,000 | 152,798,000 | 132,991,000 |